ceftipure injectable suspension suspension for injection
alke sağlik Ürünlerì san and tİc. a.Ş., turkey - ceftiofur hydrochloride - suspension for injection - 50 mg/ml
ceftipure suspension for injection
alke sağlik Ürünlerì san and tİc. a.Ş., turkey - ceftiofur - suspension for injection - 50 mg/ml
enrolen solution for injection
alke sağlik Ürünlerì san and tİc. a.Ş., turkey - enrofloxacin - solution for injection - 100 mg/ml
enrolen solution for injection
alke sağlik Ürünlerì san and tİc. a.Ş., turkey - enrofloxacin - solution for injection - 100 mg/ml
ultrapour-f pour-on solution
alke sağlik Ürünlerì san and tİc. a.Ş., turkey - flumethrin - pour-on solution - 10 mg/ml
actimisin injectable solution solution for injection
alke sağlik Ürünlerì san and tİc. a.Ş., turkey - tilmicosin - solution for injection - 300 mg/ml
actimisin injectable solution solution for injection
alke sağlik Ürünlerì san and tİc. a.Ş., turkey - tilmicosin - solution for injection - 300 mg/ml
actimisin injectable solution solution for injection
alke sağlik Ürünlerì san and tİc. a.Ş., turkey - tilmicosin - solution for injection - 300 mg/ml
alkem gabapen gabapentin 400 mg capsule blister pack
pharmacor pty ltd - gabapentin, quantity: 400 mg - capsule, hard - excipient ingredients: maize starch; lactose; purified talc; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin; sodium lauryl sulfate - alkem gabapen is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.
alkem gabapen gabapentin 300 mg capsule blister pack
pharmacor pty ltd - gabapentin, quantity: 300 mg - capsule, hard - excipient ingredients: lactose; maize starch; purified talc; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - alkem gabapen is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.